Skip to content

Bowel disorder and its homoeopathic treatment

An open-label randomized clinical study for the comparative effectiveness of constitutional homoeopathic medicine with Dysentery Compound in cases of Irritable Bowel Syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008480
Enrollment
60
Registered
2017-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Irritable Bowel Syndrome

Interventions

Intervention1: Individualized homeopathic medicine in centesimal or 50 millesimal potencies: In centesimal potencies, each dose shall consist of 4 cane sugar globules medicated with a single drop of t

Sponsors

National Institute of Homoeopathy Ministry of AYUSH Govt of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 65 years 2. Both sexes 3. Symptomatic IBS for at least 2 days/week over 3 months 4. IBS diagnosed and sub-typed as per Rome III criteria

Exclusion criteria

Exclusion criteria: 1. Patients who are too sick for consultation 2. Unable to read patient information sheets and/or not giving consent to join the study 3. Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life 4. Major gastro-intestinal surgery in last 6 months 5. Currently receiving standard therapy for IBS and/or undergoing homoeopathic treatment for chronic condition(s) 6. Pregnant and lactating women 7. Self-reported immune-compromised state 8. Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
IBS Quality of Life (IBS-QOL) questionnaireTimepoint: 3 months

Secondary

MeasureTime frame
NoneTimepoint: Not applicable

Countries

India

Contacts

Public ContactSwapan Paul

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 21, 2026